超5000倍认购,长风药业为何成为“人气王”?

CPHI制药在线
Oct 09

关注并星标CPHI制药在线10月8日,长风药业正式在港交所上市,股价一度涨超220%。在本次IPO中,长风药业计划发行约4119.8万股H股,每股14.75港元。从认购情况看,其获得5587倍的超额认购,超过了此前银诺医药的5341倍,成为港交所上市药企中的人气王。据招股书介绍,公司此次募资主要用于国内及国际已有的吸入制剂候选产品的持续研发及临床开发、以及生产设施、生产管理系统的扩张及升级等。作为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10